Detalhe da pesquisa
1.
An extended minimal model of OGTT: estimation of α- and ß-cell dysfunction, insulin resistance, and the incretin effect.
Am J Physiol Endocrinol Metab
; 326(2): E182-E205, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088864
2.
Acute changes in plasma glucose increases left ventricular systolic function in insulin-treated patients with type 2 diabetes and controls.
Diabetes Obes Metab
; 24(6): 1123-1131, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238140
3.
The effect of curcumin on hepatic fat content in individuals with obesity.
Diabetes Obes Metab
; 24(11): 2192-2202, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35775631
4.
Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study.
Cardiovasc Diabetol
; 20(1): 241, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952579
5.
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Am J Physiol Gastrointest Liver Physiol
; 316(4): G462-G472, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653341
6.
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.
Int J Mol Sci
; 20(17)2019 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31443356
7.
Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?
Diabetes Obes Metab
; 20(8): 1937-1943, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29654643
8.
Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
Diabetologia
; 60(7): 1344-1353, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28364253
9.
Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.
Diabetologia
; 57(8): 1720-5, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24879388
10.
Glucagon and type 2 diabetes: the return of the alpha cell.
Curr Diab Rep
; 14(12): 555, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344790
11.
The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity.
Endocr Connect
; 13(3)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38276866
12.
No effect of the turmeric root phenol curcumin on prednisolone-induced glucometabolic perturbations in men with overweight or obesity.
Endocr Connect
; 12(4)2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800259
13.
Long-acting amylin analogues for the management of obesity.
Curr Opin Endocrinol Diabetes Obes
; 29(2): 183-190, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066542
14.
A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment.
Front Physiol
; 13: 911616, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148302
15.
THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology.
Eur J Endocrinol
; 186(6): R93-R111, 2022 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353712
16.
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Am J Physiol Endocrinol Metab
; 300(6): E1038-46, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21386059
17.
MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.
Eur J Endocrinol
; 185(4): R93-R101, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370694
18.
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects.
Diabetes
; 70(6): 1347-1356, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722838
19.
Glucagon Clearance is Preserved in Type 2 Diabetes.
Diabetes
; 2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702780
20.
Glucagon Clearance is Preserved in Type 2 Diabetes.
Diabetes
; 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957488